on ABIVAX (EPA:ABVX)
JP Morgan Crosses Threshold in ABIVAX
On March 5, 2025, ABIVAX received a statement from JP Morgan Chase & Co. regarding a shareholding threshold crossing. On February 28, 2025, JP Morgan indirectly crossed upwards the 5% shareholding threshold in ABIVAX. Through its subsidiaries JP Morgan Securities plc and JP Morgan Securities LLC, the company now holds 3,233,863 ABIVAX shares, equivalent to 5.10% of the share capital and 4.55% of the voting rights.
This crossing results from the acquisition of shares through assimilation, including "third-party shares where right of use held" and "depository receipts" contracts. In addition, the company holds "cash-settled equity swap" contracts, exercisable at different maturity dates.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ABIVAX news